Back to School: How biopharma can reboot drug development. Access exclusive analysis here

A Hillary by any other name

Despite her claims to being a "New Democrat", and expressing astonishment at the tax burden carried by New Yorkers, Hillary Clinton continues to make it clear that she still likes her governments big, meddlesome and, in the health care arena, in the price control business. And if she wasn't able to get her way through Hillarycare, she'll settle for allowing the Canadian government to determine the prices for

Read the full 681 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers